CLINICAL_TRIALS
trial_result
· 2019-09-06
Clinical Trial Update: Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) [Phase 2]
Summary
Phase 2 clinical trial update on MT-3995 for non-alcoholic steatohepatitis (NASH) reporting efficacy and safety results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: NASH | Phase 2 | Status: COMPLETED